Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity

被引:2
|
作者
Tabuchi, Keiji [1 ]
Hara, Akira [1 ]
机构
[1] Univ Tsukuba, Dept Otolaryngol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058576, Japan
关键词
Sphingolipid; ceramide; sphingosine; ceramide-1-phosphonate (C1P); sphingosine-1-phosphate (S1P); cochlea; SPHINGOSINE 1-PHOSPHATE RECEPTOR; HAIR CELL LOSS; NEUTRAL SPHINGOMYELINASE-2; CERAMIDE; PROTEIN; METABOLISM; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; STRESS; INHIBITION;
D O I
10.2174/1874467211666180516101111
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background and Objective: Sphingolipid metabolites, including ceramide, sphingosine, and their phosphorylates (ceramide-1-phosphonate [C1P] and sphingosine-1-phosphate [S1P]), regulate diverse cellular processes including apoptosis, the cell cycle, and cellular differentiation. Recent studies have shown that these sphingolipid metabolites are generated in response to ototoxic agents and play important roles in determining the fate of cochlear hair cells in ototoxic injury. Methods: This review summarizes the current knowledge on the roles of sphingolipid mediators in cochlear ototoxicity. Results: During ototoxicity, ceramide is mainly generated via sphingomyelinase in the cochlea through a ceramide/sphingomyelin cycle from sphingomyelin. The generated ceramide is converted to other sphingolipid mediators. Ceramide and sphingosine accelerate cochlear hair cell death induced by ototoxic agents, while, C1P and S1P, on the other hand, protect cochlear hair cells. Hair cell protection of S1P is mediated by S1P receptor subtype 2 (S1PR2). Conclusion: Sphingolipid mediators play important roles in cochlear hair cell survival or death in ototoxic injury.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 50 条
  • [1] AMINOGLYCOSIDE COCHLEAR OTOTOXICITY
    MATZ, GJ
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1993, 26 (05) : 705 - 712
  • [2] COCHLEAR GENTAMICIN OTOTOXICITY
    Qin Ting-quan
    Deng Yuan-cheng
    Qi Yi-sheng
    Guo Ye
    CHINESEMEDICALJOURNAL, 1984, (02)
  • [3] COCHLEAR GENTAMICIN OTOTOXICITY
    QIN, TQ
    DENG, YC
    QI, YS
    GUO, Y
    CHINESE MEDICAL JOURNAL, 1984, 97 (02) : 123 - 130
  • [4] NEOMYCIN - OTOTOXICITY AND COCHLEAR EFFERENTS
    BROWN, RD
    DAIGNEAULT, EA
    ACTA OTO-LARYNGOLOGICA, 1973, 76 (2-3) : 128 - 135
  • [5] COCHLEAR CYTOARCHITECTURE AND RIBOSTAMYCIN OTOTOXICITY
    CATALANO, GB
    SERRA, A
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 1982, 4 (01): : 41 - 53
  • [6] Vascular effects of sphingolipid mediators
    Magyar, A.
    Orsy, P.
    Horvath, B.
    Donko, A.
    Benyo, Z.
    ACTA PHYSIOLOGICA HUNGARICA, 2009, 96 (01) : 98 - 100
  • [7] MEASUREMENT OF OTOTOXICITY IN ANIMALS BY COCHLEAR MICROPHONICS
    SCHINDLE.K
    SCHMITT, HG
    NOISSER, H
    AUDIOLOGY, 1972, 11 : 20 - 21
  • [8] COCHLEAR OTOTOXICITY OF CHLORHEXIDINE GLUCONATE IN CATS
    IGARASHI, Y
    SUZUKI, J
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1985, 242 (02): : 167 - 176
  • [9] HUMAN COCHLEAR PATHOLOGY IN GENTAMICIN OTOTOXICITY
    BACKUS, RM
    DEGROOT, JCMJ
    HUIZING, EH
    TANGE, RA
    CLINICAL OTOLARYNGOLOGY, 1985, 10 (04): : 227 - 227
  • [10] Trichloroethylene ototoxicity: Evidence for a cochlear origin
    Fechter, LD
    Liu, Y
    Herr, DW
    Crofton, KM
    TOXICOLOGICAL SCIENCES, 1998, 42 (01) : 28 - 35